Quality improvement intervention may help prevent deaths from metformin-associated lactic acid

Metformin-associated lactic acidosis (MALA) is a rare but serious adverse effect of the diabetes drug metformin in which the body accumulates too much lactic acid. Investigators developed and tested a protocol for diagnosis and treatment of MALA. Their work will be presented at ASN Kidney Week 2025 from November 5–9.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup